ReviewNeuroscience and biobehavioral reviews2020

Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.

Ewa Galaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.